<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="8" family="AkzidenzGroteskBE,Bold" color="#000000"/>
	<fontspec id="font1" size="8" family="AkzidenzGroteskBE-Md,Bold" color="#000000"/>
	<fontspec id="font2" size="8" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font3" size="7" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
	<fontspec id="font4" size="9" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font5" size="9" family="SymbolMT" color="#000000"/>
	<fontspec id="font6" size="9" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
	<fontspec id="font7" size="9" family="AkzidenzGroteskBE,Bold" color="#000000"/>
	<fontspec id="font8" size="6" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font9" size="8" family="SymbolMT" color="#000000"/>
	<fontspec id="font10" size="8" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
<text top="42" left="315" width="62" height="7" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="text"><b>Available online</b></text>
<text top="42" left="380" width="176" height="7" font="font2" id="p1_t2" reading_order_no="1" segment_no="0" tag_type="text">http://breast-cancer-research.com/content/8/5/R56</text>
<text top="758" left="511" width="45" height="7" font="font2" id="p1_t3" reading_order_no="130" segment_no="10" tag_type="text">Page 3 of 15</text>
<text top="769" left="436" width="120" height="6" font="font3" id="p1_t4" reading_order_no="131" segment_no="11" tag_type="text"><i>(page number not for citation purposes)</i></text>
<text top="285" left="57" width="240" height="9" font="font4" id="p1_t5" reading_order_no="36" segment_no="5" tag_type="text">medium with 2% fetal calf serum for 4 to 6 h with intermittent</text>
<text top="297" left="57" width="240" height="9" font="font4" id="p1_t6" reading_order_no="37" segment_no="5" tag_type="text">shaking. After brief settling, the supernatant was spun down,</text>
<text top="308" left="57" width="240" height="9" font="font4" id="p1_t7" reading_order_no="38" segment_no="5" tag_type="text">and the pellet resuspended in L-15 medium and passed</text>
<text top="320" left="57" width="59" height="9" font="font4" id="p1_t8" reading_order_no="39" segment_no="5" tag_type="text">through a 100 </text>
<text top="317" left="116" width="5" height="11" font="font5" id="p1_t9" reading_order_no="40" segment_no="5" tag_type="text">µ</text>
<text top="320" left="122" width="176" height="9" font="font4" id="p1_t10" reading_order_no="41" segment_no="5" tag_type="text">m mesh filter to remove residual undisaggre-</text>
<text top="332" left="57" width="240" height="9" font="font4" id="p1_t11" reading_order_no="42" segment_no="5" tag_type="text">gated tumour fragments, plus disaggregated 'normal' orga-</text>
<text top="344" left="57" width="240" height="9" font="font4" id="p1_t12" reading_order_no="43" segment_no="5" tag_type="text">noids and ducts as well as lobules and ducts distended with</text>
<text top="355" left="57" width="69" height="9" font="font4" id="p1_t13" reading_order_no="44" segment_no="5" tag_type="text">ductal carcinoma </text>
<text top="355" left="126" width="24" height="9" font="font6" id="p1_t14" reading_order_no="45" segment_no="5" tag_type="text"><i>in situ</i></text>
<text top="355" left="150" width="148" height="9" font="font4" id="p1_t15" reading_order_no="46" segment_no="5" tag_type="text">, leaving only small clusters and single</text>
<text top="367" left="57" width="240" height="9" font="font4" id="p1_t16" reading_order_no="47" segment_no="5" tag_type="text">cells. The latter were then reacted with the mouse monoclonal</text>
<text top="379" left="57" width="240" height="9" font="font4" id="p1_t17" reading_order_no="48" segment_no="5" tag_type="text">antibody F19 to fibroblast activation protein bound to sheep</text>
<text top="391" left="57" width="240" height="9" font="font4" id="p1_t18" reading_order_no="49" segment_no="5" tag_type="text">anti-mouse coated Dynabeads (Dynal, Paisley, UK) using the</text>
<text top="402" left="57" width="240" height="9" font="font4" id="p1_t19" reading_order_no="50" segment_no="5" tag_type="text">manufacturer's protocols. Almost all desmoplastic fibroblasts</text>
<text top="414" left="57" width="240" height="9" font="font4" id="p1_t20" reading_order_no="51" segment_no="5" tag_type="text">associated with breast cancers express this antigen strongly.</text>
<text top="426" left="57" width="240" height="9" font="font4" id="p1_t21" reading_order_no="52" segment_no="5" tag_type="text">Cells attached to beads were removed with a Dynal MP40</text>
<text top="438" left="57" width="240" height="9" font="font4" id="p1_t22" reading_order_no="53" segment_no="5" tag_type="text">magnet; F19-negative cells were then allowed to sediment</text>
<text top="449" left="57" width="240" height="9" font="font4" id="p1_t23" reading_order_no="54" segment_no="5" tag_type="text">under unit gravity for 2 to 3 h (to remove most lymphocytes).</text>
<text top="461" left="57" width="240" height="9" font="font4" id="p1_t24" reading_order_no="55" segment_no="5" tag_type="text">The resulting preparation was then screened by phase con-</text>
<text top="473" left="57" width="240" height="9" font="font4" id="p1_t25" reading_order_no="56" segment_no="5" tag_type="text">trast microscopy to identify those preparations in which there</text>
<text top="485" left="57" width="240" height="9" font="font4" id="p1_t26" reading_order_no="57" segment_no="5" tag_type="text">were few if any microvessels (the other main potential stromal</text>
<text top="496" left="57" width="240" height="9" font="font4" id="p1_t27" reading_order_no="58" segment_no="5" tag_type="text">contaminant not removed by fibroblast activation protein sort-</text>
<text top="508" left="57" width="240" height="9" font="font4" id="p1_t28" reading_order_no="59" segment_no="5" tag_type="text">ing), or normal tissue elements, such as ducts or acini's. Of the</text>
<text top="520" left="57" width="240" height="9" font="font4" id="p1_t29" reading_order_no="60" segment_no="5" tag_type="text">50 samples, 15 were selected for this study, based on the cri-</text>
<text top="532" left="57" width="29" height="9" font="font4" id="p1_t30" reading_order_no="61" segment_no="5" tag_type="text">teria of </text>
<text top="529" left="86" width="5" height="11" font="font5" id="p1_t31" reading_order_no="62" segment_no="5" tag_type="text">≥</text>
<text top="532" left="91" width="206" height="9" font="font4" id="p1_t32" reading_order_no="63" segment_no="5" tag_type="text">80% malignant cell content as determined by phase-</text>
<text top="543" left="57" width="85" height="9" font="font4" id="p1_t33" reading_order_no="64" segment_no="5" tag_type="text">contrast examination, </text>
<text top="541" left="142" width="5" height="11" font="font5" id="p1_t34" reading_order_no="65" segment_no="5" tag_type="text">≥</text>
<text top="543" left="147" width="150" height="9" font="font4" id="p1_t35" reading_order_no="66" segment_no="5" tag_type="text">80% viability (as determined by trypan</text>
<text top="555" left="57" width="240" height="9" font="font4" id="p1_t36" reading_order_no="67" segment_no="5" tag_type="text">blue exclusion) and the integrity of its total RNA. The purity of</text>
<text top="567" left="57" width="240" height="9" font="font4" id="p1_t37" reading_order_no="68" segment_no="5" tag_type="text">both normal and malignant epithelial preparations is illustrated</text>
<text top="579" left="57" width="240" height="9" font="font4" id="p1_t38" reading_order_no="69" segment_no="5" tag_type="text">in Additional file<a href=""> 1. Informe</a>d consent to use this material for</text>
<text top="590" left="57" width="240" height="9" font="font4" id="p1_t39" reading_order_no="70" segment_no="5" tag_type="text">scientific research was obtained, and details of the pathology</text>
<text top="602" left="57" width="240" height="9" font="font4" id="p1_t40" reading_order_no="71" segment_no="5" tag_type="text">of the individual tumours are given as Additional file 2. RNA</text>
<text top="614" left="57" width="240" height="9" font="font4" id="p1_t41" reading_order_no="72" segment_no="5" tag_type="text">was prepared from individual samples by standard Trizol meth-</text>
<text top="626" left="57" width="240" height="9" font="font4" id="p1_t42" reading_order_no="73" segment_no="5" tag_type="text">ods and pooled to give a luminal, a myoepithelial and a malig-</text>
<text top="637" left="57" width="156" height="9" font="font4" id="p1_t43" reading_order_no="74" segment_no="5" tag_type="text">nant RNA sample of &gt;1 mg for analysis.</text>
<text top="661" left="57" width="64" height="8" font="font7" id="p1_t44" reading_order_no="75" segment_no="8" tag_type="title"><b>MPSS analysis</b></text>
<text top="673" left="57" width="240" height="9" font="font4" id="p1_t45" reading_order_no="76" segment_no="9" tag_type="text">MPSS was performed by Lynx Therapeutics, (CA, USA)</text>
<text top="684" left="57" width="240" height="9" font="font4" id="p1_t46" reading_order_no="77" segment_no="9" tag_type="text">according to the Megaclone 'signature' protoc<a href="">ol [18,19].</a></text>
<text top="696" left="57" width="240" height="9" font="font4" id="p1_t47" reading_order_no="78" segment_no="9" tag_type="text">Briefly for each library synthesis, after DNase treatment of</text>
<text top="708" left="57" width="80" height="9" font="font4" id="p1_t48" reading_order_no="79" segment_no="9" tag_type="text">approximately 300 </text>
<text top="705" left="136" width="5" height="11" font="font5" id="p1_t49" reading_order_no="80" segment_no="9" tag_type="text">µ</text>
<text top="708" left="142" width="155" height="9" font="font4" id="p1_t50" reading_order_no="81" segment_no="9" tag_type="text">g total RNA from normal luminal and</text>
<text top="720" left="57" width="240" height="9" font="font4" id="p1_t51" reading_order_no="82" segment_no="9" tag_type="text">malignant breast epithelial pools, cDNA was generated from</text>
<text top="285" left="315" width="240" height="9" font="font4" id="p1_t52" reading_order_no="83" segment_no="6" tag_type="text">poly(A)+ RNA, and amplified copies of each cDNA clone were</text>
<text top="297" left="315" width="240" height="9" font="font4" id="p1_t53" reading_order_no="84" segment_no="6" tag_type="text">attached to beads. The sequence adjacent to the poly(A) prox-</text>
<text top="308" left="315" width="18" height="9" font="font4" id="p1_t54" reading_order_no="85" segment_no="6" tag_type="text">imal </text>
<text top="308" left="334" width="17" height="9" font="font6" id="p1_t55" reading_order_no="86" segment_no="6" tag_type="text"><i>Dpn</i></text>
<text top="308" left="351" width="205" height="9" font="font4" id="p1_t56" reading_order_no="87" segment_no="6" tag_type="text">II site was determined by cycles of ligations to fluo-</text>
<text top="320" left="315" width="240" height="9" font="font4" id="p1_t57" reading_order_no="88" segment_no="6" tag_type="text">rescently tagged 'decoding' oligonucleotides and cleavages</text>
<text top="332" left="315" width="240" height="9" font="font4" id="p1_t58" reading_order_no="89" segment_no="6" tag_type="text">by restriction enzymes. Each sequence signature comprises</text>
<text top="344" left="315" width="15" height="9" font="font4" id="p1_t59" reading_order_no="90" segment_no="6" tag_type="text">the </text>
<text top="344" left="330" width="17" height="9" font="font6" id="p1_t60" reading_order_no="91" segment_no="6" tag_type="text"><i>Dpn</i></text>
<text top="344" left="347" width="209" height="9" font="font4" id="p1_t61" reading_order_no="92" segment_no="6" tag_type="text">II restriction recognition site (GATC) and 13 contigu-</text>
<text top="355" left="315" width="240" height="9" font="font4" id="p1_t62" reading_order_no="93" segment_no="6" tag_type="text">ous nucleotides. The raw data resulted from four sequencing</text>
<text top="367" left="315" width="240" height="9" font="font4" id="p1_t63" reading_order_no="94" segment_no="6" tag_type="text">runs, collected in two reading frames offset by two nucleotides</text>
<text top="379" left="315" width="240" height="9" font="font4" id="p1_t64" reading_order_no="95" segment_no="6" tag_type="text">relative to the anchoring restriction enzyme site and generat-</text>
<text top="391" left="315" width="124" height="9" font="font4" id="p1_t65" reading_order_no="96" segment_no="6" tag_type="text">ing approximately 2 to 3 × 10</text>
<text top="390" left="439" width="6" height="6" font="font8" id="p1_t66" reading_order_no="97" segment_no="6" tag_type="text">6 </text>
<text top="391" left="446" width="110" height="9" font="font4" id="p1_t67" reading_order_no="98" segment_no="6" tag_type="text">sequences. Signatures that</text>
<text top="402" left="315" width="240" height="9" font="font4" id="p1_t68" reading_order_no="99" segment_no="6" tag_type="text">were seen in at least two independent runs (reproducible) and</text>
<text top="414" left="315" width="241" height="9" font="font4" id="p1_t69" reading_order_no="100" segment_no="6" tag_type="text">were present at a frequency of more than three transcripts per</text>
<text top="426" left="315" width="240" height="9" font="font4" id="p1_t70" reading_order_no="101" segment_no="6" tag_type="text">million (tpm) in one sample (significant) were selected for fur-</text>
<text top="438" left="315" width="51" height="9" font="font4" id="p1_t71" reading_order_no="102" segment_no="6" tag_type="text">ther analysis.</text>
<text top="461" left="315" width="240" height="9" font="font4" id="p1_t72" reading_order_no="103" segment_no="7" tag_type="text">As a basis for the matching of signature sequences to tran-</text>
<text top="473" left="315" width="240" height="9" font="font4" id="p1_t73" reading_order_no="104" segment_no="7" tag_type="text">scripts, we used our own reconstitution of the human tran-</text>
<text top="485" left="315" width="241" height="9" font="font4" id="p1_t74" reading_order_no="105" segment_no="7" tag_type="text">scriptome database (H<a href="">TR) [21-23] </a>based on a comprehensive</text>
<text top="496" left="315" width="241" height="9" font="font4" id="p1_t75" reading_order_no="106" segment_no="7" tag_type="text">set of cDNA to genome alignments that are merged into gene</text>
<text top="508" left="315" width="240" height="9" font="font4" id="p1_t76" reading_order_no="107" segment_no="7" tag_type="text">models representing the detailed structure of human tran-</text>
<text top="520" left="315" width="240" height="9" font="font4" id="p1_t77" reading_order_no="108" segment_no="7" tag_type="text">scribed regions. Each HTR contains a cluster of cDNA</text>
<text top="532" left="315" width="241" height="9" font="font4" id="p1_t78" reading_order_no="109" segment_no="7" tag_type="text">sequences, similarly to the NCBI/UniGene database. The</text>
<text top="543" left="315" width="240" height="9" font="font4" id="p1_t79" reading_order_no="110" segment_no="7" tag_type="text">annotation of the signature was then performed in two steps</text>
<text top="555" left="315" width="240" height="9" font="font4" id="p1_t80" reading_order_no="111" segment_no="7" tag_type="text">as described previously [<a href="">22]</a>, using the NCBI35 assembly of</text>
<text top="567" left="315" width="240" height="9" font="font4" id="p1_t81" reading_order_no="112" segment_no="7" tag_type="text">the human genome. Firstly, a 'signature-centric' annotation</text>
<text top="579" left="315" width="240" height="9" font="font4" id="p1_t82" reading_order_no="113" segment_no="7" tag_type="text">was performed, where sequence signatures were mapped to</text>
<text top="590" left="315" width="240" height="9" font="font4" id="p1_t83" reading_order_no="114" segment_no="7" tag_type="text">either one or more transcribed regions of the genome, includ-</text>
<text top="602" left="315" width="240" height="9" font="font4" id="p1_t84" reading_order_no="115" segment_no="7" tag_type="text">ing repetitive sequences, ribosomal, mitochondrial and non-</text>
<text top="614" left="315" width="240" height="9" font="font4" id="p1_t85" reading_order_no="116" segment_no="7" tag_type="text">mapped transcripts. In the second step, only signatures from</text>
<text top="626" left="315" width="240" height="9" font="font4" id="p1_t86" reading_order_no="117" segment_no="7" tag_type="text">the 'signature-centric' annotation that matched exactly or had</text>
<text top="637" left="315" width="241" height="9" font="font4" id="p1_t87" reading_order_no="118" segment_no="7" tag_type="text">one nucleotide mismatch to known transcribed regions were</text>
<text top="649" left="315" width="240" height="9" font="font4" id="p1_t88" reading_order_no="119" segment_no="7" tag_type="text">retained to form the 'gene-centric' version. When different</text>
<text top="661" left="315" width="241" height="9" font="font4" id="p1_t89" reading_order_no="120" segment_no="7" tag_type="text">sequence signatures mapped to the same gene, counts were</text>
<text top="673" left="315" width="234" height="9" font="font4" id="p1_t90" reading_order_no="121" segment_no="7" tag_type="text">combined. To identify genes with significant differences (</text>
<text top="673" left="550" width="6" height="9" font="font6" id="p1_t91" reading_order_no="122" segment_no="7" tag_type="text"><i>P</i></text>
<text top="684" left="315" width="23" height="9" font="font4" id="p1_t92" reading_order_no="123" segment_no="7" tag_type="text">value </text>
<text top="682" left="340" width="5" height="11" font="font5" id="p1_t93" reading_order_no="124" segment_no="7" tag_type="text">≤</text>
<text top="684" left="345" width="211" height="9" font="font4" id="p1_t94" reading_order_no="125" segment_no="7" tag_type="text"> 0.05) in representation in the two RNA pools, the</text>
<text top="696" left="315" width="240" height="9" font="font4" id="p1_t95" reading_order_no="126" segment_no="7" tag_type="text">absolute difference in abundance between the malignant and</text>
<text top="708" left="315" width="237" height="9" font="font4" id="p1_t96" reading_order_no="127" segment_no="7" tag_type="text">the normal epithelial RNA sample was determined and log</text>
<text top="712" left="552" width="4" height="6" font="font8" id="p1_t97" reading_order_no="128" segment_no="7" tag_type="text">2</text>
<text top="720" left="315" width="234" height="9" font="font4" id="p1_t98" reading_order_no="129" segment_no="7" tag_type="text">transformed, resulting in a relative expression measurement.</text>
<text top="85" left="57" width="28" height="7" font="font0" id="p1_t99" reading_order_no="2" segment_no="1" tag_type="title"><b>Table 1</b></text>
<text top="104" left="57" width="237" height="7" font="font0" id="p1_t100" reading_order_no="3" segment_no="2" tag_type="text"><b>Numerical analysis of massively parallel signature sequencing</b></text>
<text top="123" left="260" width="93" height="7" font="font2" id="p1_t101" reading_order_no="4" segment_no="3" tag_type="table">Malignant breast epithelium</text>
<text top="123" left="429" width="87" height="7" font="font2" id="p1_t102" reading_order_no="5" segment_no="3" tag_type="table">Normal luminal epithelium</text>
<text top="139" left="61" width="72" height="7" font="font2" id="p1_t103" reading_order_no="6" segment_no="3" tag_type="table">Sequence signatures</text>
<text top="139" left="294" width="25" height="7" font="font2" id="p1_t104" reading_order_no="7" segment_no="3" tag_type="table">24,288</text>
<text top="139" left="460" width="25" height="7" font="font2" id="p1_t105" reading_order_no="8" segment_no="3" tag_type="table">28,404</text>
<text top="154" left="61" width="97" height="7" font="font2" id="p1_t106" reading_order_no="9" segment_no="3" tag_type="table">Uniquely mapped signatures</text>
<text top="154" left="294" width="25" height="7" font="font2" id="p1_t107" reading_order_no="10" segment_no="3" tag_type="table">14,245</text>
<text top="154" left="460" width="25" height="7" font="font2" id="p1_t108" reading_order_no="11" segment_no="3" tag_type="table">10,249</text>
<text top="170" left="61" width="71" height="7" font="font2" id="p1_t109" reading_order_no="12" segment_no="3" tag_type="table">Unique HTR clusters</text>
<text top="170" left="281" width="48" height="7" font="font2" id="p1_t110" reading_order_no="13" segment_no="3" tag_type="table">8,421 (3,191)</text>
<text top="170" left="329" width="3" height="5" font="font8" id="p1_t111" reading_order_no="14" segment_no="3" tag_type="table">a</text>
<text top="170" left="447" width="48" height="7" font="font2" id="p1_t112" reading_order_no="15" segment_no="3" tag_type="table">6,477 (1,297)</text>
<text top="170" left="495" width="3" height="5" font="font8" id="p1_t113" reading_order_no="16" segment_no="3" tag_type="table">a</text>
<text top="185" left="61" width="51" height="7" font="font2" id="p1_t114" reading_order_no="17" segment_no="3" tag_type="table">Dynamic range</text>
<text top="185" left="286" width="41" height="7" font="font2" id="p1_t115" reading_order_no="18" segment_no="3" tag_type="table">&lt;9,808 tpm</text>
<text top="185" left="450" width="46" height="7" font="font2" id="p1_t116" reading_order_no="19" segment_no="3" tag_type="table">&lt;35,847 tpm</text>
<text top="201" left="61" width="117" height="7" font="font2" id="p1_t117" reading_order_no="20" segment_no="3" tag_type="table">Differentially expressed transcripts</text>
<text top="201" left="286" width="41" height="7" font="font2" id="p1_t118" reading_order_no="21" segment_no="3" tag_type="table">4,311 T &gt; L</text>
<text top="201" left="452" width="41" height="7" font="font2" id="p1_t119" reading_order_no="22" segment_no="3" tag_type="table">2,242 L &gt; T</text>
<text top="217" left="61" width="485" height="7" font="font2" id="p1_t120" reading_order_no="23" segment_no="4" tag_type="text">Sequence signatures represent the total number of sequences obtained by massively parallel signature sequencing (MPSS). Uniquely mapped </text>
<text top="225" left="61" width="491" height="7" font="font2" id="p1_t121" reading_order_no="24" segment_no="4" tag_type="text">signatures correspond to the total number of human transcriptome clusters identified and retained in the 'gene-centric' annotation. Unique human </text>
<text top="233" left="61" width="405" height="7" font="font2" id="p1_t122" reading_order_no="25" segment_no="4" tag_type="text">transcriptome database (HTR) clusters are transcripts that mapped to a single human cluster and had an abundance of </text>
<text top="231" left="466" width="4" height="10" font="font9" id="p1_t123" reading_order_no="26" segment_no="4" tag_type="text">≥</text>
<text top="233" left="470" width="81" height="7" font="font2" id="p1_t124" reading_order_no="27" segment_no="4" tag_type="text">3 transcripts per million </text>
<text top="241" left="61" width="359" height="7" font="font2" id="p1_t125" reading_order_no="28" segment_no="4" tag_type="text">(tpm) (approximately one transcript/cell). As described in Materials and methods, statistically significantly (</text>
<text top="241" left="419" width="7" height="7" font="font10" id="p1_t126" reading_order_no="29" segment_no="4" tag_type="text"><i>P </i></text>
<text top="239" left="427" width="4" height="10" font="font9" id="p1_t127" reading_order_no="30" segment_no="4" tag_type="text">≤</text>
<text top="241" left="431" width="102" height="7" font="font2" id="p1_t128" reading_order_no="31" segment_no="4" tag_type="text"> 0.05) differentially expressed </text>
<text top="249" left="61" width="433" height="7" font="font2" id="p1_t129" reading_order_no="32" segment_no="4" tag_type="text">transcripts were determined and separated into tumour (T) over normal luminal (L) or vice verse, depending on their fold change. </text>
<text top="249" left="494" width="3" height="5" font="font8" id="p1_t130" reading_order_no="33" segment_no="4" tag_type="text">a</text>
<text top="249" left="496" width="55" height="7" font="font2" id="p1_t131" reading_order_no="34" segment_no="4" tag_type="text">Corresponds to </text>
<text top="257" left="61" width="133" height="7" font="font2" id="p1_t132" reading_order_no="35" segment_no="4" tag_type="text">HTR clusters found in only one sample.</text>
</page>
</pdf2xml>
